Science Highlights & News

May 2009 - The Scientist
Keith Moffat Keith Moffat Profiled in The Scientist

In an extended profile, BioCARS principal investigator Keith Moffat recounts a career spent inventing tools that light up molecules in motion.

The profile is a companion piece to a story tracing the new field of light-oxygen-voltage–based biological signaling. Read article>

More News ›

Facility News

Workshop Concludes Successfully

28931D08

Dec. 18, 2008 - In late November, BioCARS hosted a three-day workshop on time-resolved crystallography and Laue diffraction. Thirty-one participants represented 21 research groups. The international user community was represented by participants from the Czech Republic, Denmark, Canada, and Australia. Many participants left the workshop with plans for designing time-resolved experiments on their own biological systems. Full story ›

Tutorial Introduces Laue Data Processing at BioCARS (Mar08)
New to Laue diffraction? Start here!

More News ›

BioCARS is a national user facility for synchrotron-based macromolecular crystallography at Sector 14 of the Advanced Photon Source, Argonne National Laboratory. BioCARS is an integral part of the multi-institutional and multi-disciplinary Consortium for Advanced Radiation Sources (CARS), managed by the University of Chicago Center for Advanced Radiation Sources.

null

The mission of BioCARS is to develop the resources and facilities necessary to foster frontier research in the field of macromolecular crystallography. BioCARS provides state-of-the art facilities, scientific and technical support for Laue and time-resolved crystallography, studies of macromolecular assemblies that form crystals with large unit cells, MAD phasing, and ultra-high resolution crystallography. In all cases, the goal is to understand basic biological processes in structural terms, at the atomic resolution level. Scientific problems addressed by BioCARS users and staff are fundamental to basic science, highly relevant to significant biomedical problems and of great practical importance to the pharmaceutical and biotechnology industries.

BioCARS operates two experimental stations, embedded in a Biosafety Level 3 (BSL-3) facility. This BSL-3 synchrotron-based capability is unique in the United States and permits safe studies of biohazardous materials, such as pathogenic human viruses.

More about BioCARS: Facility and Scientific Mission › (PDF)

Time-resolved crystallography: past, present and future › (PDF)

 

 

Apply for BioCARS beamtime: Submit a proposal through the APS General User Program ›

null null

BioCARS receives support (grant RR007707) from the National Center for Research Resources of the National Institutes of Health.